Clinical Trial Update: Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

View source ↗

Summary

Completed trial evaluating potential off-label use of dabigatran etexilate in Europe for atrial fibrillation; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2017-10-16